🐜
|
A dynamic COVID-19 immune signature includes associations with poor prognosis
50 auth.
Adam G. Laing,
A. Lorenc,
Irene del Molino del Barrio,
Abhishek Das,
M. Fish,
L. Monin,
M. Muñoz-Ruiz,
Duncan R. McKenzie,
T. Hayday,
Isaac Francos-Quijorna,
S. Kamdar,
Magdalene Joseph,
Daniel Davies,
Richard Davis,
Aislinn Jennings,
...
I. Zlatareva,
P. Vantourout,
Yin Wu,
Vasiliki Sofra,
Florencia Cano,
M. Greco,
E. Theodoridis,
Joshua Freedman,
S. Gee,
J. Chan,
Sarah Ryan,
Eva Bugallo-Blanco,
P. Peterson,
K. Kisand,
L. Haljasmägi,
L. Chadli,
P. Moingeon,
L. Martinez,
B. Merrick,
K. Bisnauthsing,
Kate Brooks,
Mohammad A. A. Ibrahim,
J. Mason,
Federico Lopez Gomez,
K. Babalola,
Sultan Abdul-Jawad,
J. Cason,
C. Mant,
J. Seow,
C. Graham,
K. Doores,
F. Di Rosa,
J. Edgeworth,
M. Shankar-Hari,
A. Hayday
|
9 |
2020 |
9 🐜
|
🐜
|
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
44 auth.
L. Monin,
Adam G. Laing,
M. Muñoz-Ruiz,
Duncan R. McKenzie,
Irene del Molino del Barrio,
T. Alaguthurai,
C. Domingo-Vila,
T. Hayday,
C. Graham,
J. Seow,
Sultan Abdul-Jawad,
S. Kamdar,
E. Harvey-Jones,
R. Graham,
J. Cooper,
...
Muhammad Khan,
Jennifer Vidler,
Helen Kakkassery,
Shubhankar Sinha,
Richard Davis,
L. Dupont,
I. Francos Quijorna,
Charlotte O’Brien-Gore,
Puay Ling Lee,
J. Eum,
María Conde Poole,
Magdalene Joseph,
Daniel Davies,
Yin Wu,
A. Swampillai,
B. North,
A. Montes,
M. Harries,
A. Rigg,
J. Spicer,
M. Malim,
P. Fields,
P. Patten,
F. Di Rosa,
S. Papa,
T. Tree,
K. Doores,
A. Hayday,
S. Irshad
|
8 |
2021 |
8 🐜
|
🐜
|
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
29 auth.
C. Graham,
J. Seow,
I. Huettner,
H. Khan,
N. Kouphou,
S. Acors,
H. Winstone,
S. Pickering,
R. Galão,
L. Dupont,
M. Lista,
Jose M. Jimenez-Guardeño,
Adam G. Laing,
Yin Wu,
Magdalene Joseph,
...
L. Muir,
M. V. van Gils,
Weng M. Ng,
Helen M. E. Duyvesteyn,
Yuguang Zhao,
T. Bowden,
M. Shankar-Hari,
Annachiara Rosa,
P. Cherepanov,
Laura E. McCoy,
A. Hayday,
S. Neil,
M. Malim,
K. Doores
|
6 |
2021 |
6 🐜
|
🐜
|
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients
51 auth.
Sultan Abdul-Jawad,
L. Bau,
T. Alaguthurai,
Irene del Molino del Barrio,
Adam G. Laing,
T. Hayday,
L. Monin,
M. Muñoz-Ruiz,
L. Mcdonald,
I. Francos Quijorna,
Duncan R. McKenzie,
Richard Davis,
A. Lorenc,
J. Chan,
Sarah Ryan,
...
Eva Bugallo-Blanco,
Rozalyn Yorke,
S. Kamdar,
M. Fish,
I. Zlatareva,
P. Vantourout,
Aislinn Jennings,
S. Gee,
K. Doores,
K. Bailey,
Sophie Hazell,
J. de Naurois,
C. Moss,
B. Russell,
A. Khan,
M. Rowley,
R. Benjamin,
D. Enting,
D. Alrifai,
Yin Wu,
You Zhou,
P. Barber,
T. Ng,
J. Spicer,
M. van Hemelrijck,
Mayur Kumar,
Jennifer Vidler,
Y. Lwin,
P. Fields,
S. Karagiannis,
A. Coolen,
A. Rigg,
S. Papa,
A. Hayday,
P. Patten,
S. Irshad
|
6 |
2021 |
6 🐜
|
🐜
|
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
41 auth.
Leticia Monin-Aldama,
Adam G. Laing,
M. Muñoz-Ruiz,
Duncan R. McKenzie,
Irene del Molino del Barrio,
T. Alaguthurai,
C. Domingo-Vila,
T. Hayday,
C. Graham,
J. Seow,
Sultan Abdul-Jawad,
S. Kamdar,
E. Harvey-Jones,
R. Graham,
J. Cooper,
...
Muhammad Khan,
Jennifer Vidler,
Helen Kakkassery,
Sinha Shubhankar,
Richard Davis,
L. Dupont,
I. F. Quijorna,
P. Lee,
J. Eum,
M. Poole,
Magdalene Joseph,
Daniel Davies,
Yin Wu,
A. Montes,
Mark Harries,
A. Rigg,
J. Spicer,
M. Malim,
P. Fields,
P. Patten,
F. Rosa,
S. Papa,
T. Tree,
K. Doores,
A. Hayday,
S. Irshad
|
5 |
2021 |
5 🐜
|
🐜
|
A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis
48 auth.
Adam G. Laing,
A. Lorenc,
Irene del Molino del Barrio,
Abhishek Das,
M. Fish,
L. Monin,
M. Muñoz-Ruiz,
Duncan R. McKenzie,
T. Hayday,
Isaac Francos-Quijorna,
S. Kamdar,
Magdalene Joseph,
Daniel Davies,
Richard Davis,
Aislinn Jennings,
...
I. Zlatareva,
P. Vantourout,
Yin Wu,
Vasiliki Sofra,
Florencia Cano,
M. Greco,
E. Theodoridis,
Joshua Freedman,
S. Gee,
Julie Nuo En Chan,
Sarah Ryan,
Eva Bugallo-Blanco,
P. Peterson,
K. Kisand,
L. Haljasmägi,
L. Martinez,
B. Merrick,
K. Bisnauthsing,
Kate Brooks,
Mohammad A. A. Ibrahim,
J. Mason,
F. L. Gomez,
K. Babalola,
Sultan Abdul- Jawad,
J. Cason,
C. Mant,
K. Doores,
J. Seow,
C. Graham,
F. Rosa,
J. Edgeworth,
M. Shankar-Hari,
A. Hayday
|
5 |
2020 |
5 🐜
|
🐜
|
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
50 auth.
Adam G. Laing,
A. Lorenc,
Irene del Molino del Barrio,
Abhishek Das,
M. Fish,
L. Monin,
M. Muñoz-Ruiz,
Duncan R. McKenzie,
T. Hayday,
Isaac Francos-Quijorna,
S. Kamdar,
Magdalene Joseph,
Daniel Davies,
Richard Davis,
Aislinn Jennings,
...
I. Zlatareva,
P. Vantourout,
Yin Wu,
Vasiliki Sofra,
Florencia Cano,
M. Greco,
E. Theodoridis,
Joshua Freedman,
S. Gee,
J. Chan,
Sarah Ryan,
Eva Bugallo-Blanco,
P. Peterson,
K. Kisand,
L. Haljasmägi,
L. Chadli,
P. Moingeon,
L. Martinez,
B. Merrick,
K. Bisnauthsing,
Kate Brooks,
Mohammad A. A. Ibrahim,
J. Mason,
Federico Lopez Gomez,
K. Babalola,
Sultan Abdul-Jawad,
J. Cason,
C. Mant,
J. Seow,
C. Graham,
K. Doores,
F. Di Rosa,
J. Edgeworth,
M. Shankar-Hari,
A. Hayday
|
5 |
2020 |
5 🐜
|
🐜
|
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
27 auth.
C. Graham,
J. Seow,
I. Huettner,
H. Khan,
N. Kouphou,
S. Acors,
H. Winstone,
S. Pickering,
R. Galão,
M. Lista,
Jose M. Jimenez-Guardeño,
Adam G. Laing,
Yin Wu,
Magdalene Joseph,
L. Muir,
...
Weng M. Ng,
Helen M. E. Duyvesteyn,
Yuguang Zhao,
T. Bowden,
M. Shankar-Hari,
Annachiara Rosa,
P. Cherepanov,
Laura E. McCoy,
A. Hayday,
S. Neil,
M. Malim,
K. Doores
|
5 |
2021 |
5 🐜
|
🐜
|
A dynamic COVID-19 immune signature includes associations with poor prognosis
50 auth.
Adam G. Laing,
A. Lorenc,
Irene del Molino del Barrio,
Abhishek Das,
M. Fish,
L. Monin,
M. Muñoz-Ruiz,
Duncan R. McKenzie,
T. Hayday,
Isaac Francos-Quijorna,
S. Kamdar,
Magdalene Joseph,
Daniel Davies,
Richard Davis,
Aislinn Jennings,
...
I. Zlatareva,
P. Vantourout,
Yin Wu,
Vasiliki Sofra,
Florencia Cano,
M. Greco,
E. Theodoridis,
Joshua Freedman,
S. Gee,
J. Chan,
Sarah Ryan,
Eva Bugallo-Blanco,
P. Peterson,
K. Kisand,
L. Haljasmägi,
L. Chadli,
P. Moingeon,
L. Martinez,
B. Merrick,
K. Bisnauthsing,
Kate Brooks,
Mohammad A. A. Ibrahim,
J. Mason,
Federico Lopez Gomez,
K. Babalola,
Sultan Abdul-Jawad,
J. Cason,
C. Mant,
J. Seow,
C. Graham,
K. Doores,
F. Di Rosa,
J. Edgeworth,
M. Shankar-Hari,
A. Hayday
|
4 |
2020 |
4 🐜
|
🐢
|
PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy
16 auth.
Daniel Davies,
S. Kamdar,
Richard T Woolf,
I. Zlatareva,
M. L. Iannitto,
Cienne Morton,
Yasmin Haque,
Hannah Martin,
D. Biswas,
Susan Ndagire,
...
Martina Munonyara,
Cheryl Gillett,
Olga O’Neill,
Oliver Nussbaumer,
A. Hayday,
Yin Wu
|
4 |
2024 |
4 🐢
|